Genuit Dividends - GEN

Best deals to access real time data!
Level 2 Basic Monthly Subscription for only ~~£62.08~~
Silver Monthly Subscription for only ~~£17.37~~
UK/US Silver Monthly Subscription for only £30.59
VAT not included

Stock Name	Stock Symbol	Market	Stock Type
Genuit Group Plc	GEN	London	Ordinary Share

	Price Change	Price Change %	Stock Price	Last Trade
	-3.00	-0.78%	379.50	16:35:14

Open Price	Low Price	High Price	Close Price	Previous Close
375.50	370.00	383.50	379.50	382.50

more quote information »

Industry Sector
INDUSTRIAL ENGINEERING

Genuit GEN Dividends History

Announcement Date	Type	Currency	Dividend Amount	Period Start	Period End	Ex Date	Record Date	Payment Date	Total Dividend Amount
16/03/2022	Final	GBX	8.2	31/12/2020	31/12/2021	21/04/2022	22/04/2022	25/05/2022	12.2
17/08/2021	Interim	GBX	4	30/12/2020	30/06/2021	02/09/2021	03/09/2021	24/09/2021	0
16/03/2021	Final	GBX	4.8	31/12/2019	31/12/2020	22/04/2021	23/04/2021	26/05/2021	4.8
13/08/2019	Interim	GBX	4	30/12/2018	30/06/2019	29/08/2019	30/08/2019	20/09/2019	4
19/03/2019	Final	GBX	7.9	31/12/2017	31/12/2018	18/04/2019	23/04/2019	29/05/2019	11.6
14/08/2018	Interim	GBX	3.7	30/12/2017	30/06/2018	30/08/2018	31/08/2018	21/09/2018	0
20/03/2018	Final	GBX	7.5	31/12/2016	31/12/2017	19/04/2018	20/04/2018	25/05/2018	11.1
08/08/2017	Interim	GBX	3.6	30/12/2016	30/06/2017	24/08/2017	25/08/2017	22/09/2017	0
30/03/2017	Final	GBX	7	31/12/2015	31/12/2016	27/04/2017	28/04/2017	02/06/2017	10.1
16/08/2016	Interim	GBX	3.1	30/12/2015	30/06/2016	25/08/2016	26/08/2016	23/09/2016	0
31/03/2016	Final	GBX	3.2	31/12/2014	31/12/2015	28/04/2016	29/04/2016	01/06/2016	5.5
20/08/2015	Interim	GBX	2.3	30/12/2014	30/06/2015	27/08/2015	28/08/2015	25/09/2015	0
26/03/2015	Final	GBX	3	31/12/2013	31/12/2014	07/05/2015	08/05/2015	28/05/2015	4.5
18/08/2014	Interim	GBX	1.5	30/12/2013	30/06/2014	27/08/2014	29/08/2014	26/09/2014	0

Top Dividend Posts

Date	Subject
18/2/2022 13:37	km18: ...from last year... Company overview: Genuit Group is actually the new name of Polypipe Group plc. They provide sustainable solutions for water, climate and ventilation management. Sustainability is at the core of the firm’s strategy, driven by constant innovations. Genuit benefits from the active plans of governments across the globe to achieve net zero strategies and promote ESG activities and foresees geographic reach to be a major driver of growth for the group in the long term. Blended approach for growth, with several acquisitions and continuous Capex seems to be working for the company in the long run, as both revenues and EPS have been growing steadily over the past 6 years, with the sole exception the catharsis of 2020. Fundamentally the company is also supported by a solid history of debt retirement and cash generation. the half-year report sounds very promising. The group revenue was 32.5% above the 2019 figure (yes, that is a 3rd above the covid free year), driven by a significant raise in residential business at £183.8m (64% growth yoy lfl basis). The sole red flag on the report comes in the face of pressured margins, coming from the rising input costs. This has been balanced very nicely by 8% increase in prices for final customers, which proves the company’s brand recognition. The labour supply issues several sectors are experiencing seems to be fading at Genuit, but we suggest keeping your eyes open for September for further guidance on the direction of the “pingdemic”. Genuit’s exposure to pen air projects is what supported the performance during the lockdowns, but the group saw drop in the commercial side of the sector. So, overall growth there is mediocre at 8.3%. Analyst consensus is expecting 9% increase in profit, built on the residentials and the acquisitions which are performing quite well. The board is expecting “underlying operating profit for FY to be ahead of expectations”....from WealthOracleAM https://wealthoracle.co.uk/detailed-result-full/GEN/95 Read Full Thread Follow Reply
30/8/2021 00:13	philanderer: xd thursday morning for the 4p dividend. Read Full Thread Follow Reply
21/4/2021 14:50	philanderer: xd tomorrow morning for the 4.8p dividend Read Full Thread Follow Reply
02/9/2006 21:10	rambutan2: yes, the sphere idea crossed my mind. i trawled through the 05 report and accounts earlier today, in part to remind myself why/whether i should still be holding. i decided to hang on in, although as always, was still not convinced that the gen model will ever be really profitable. i think it quite possible that the interims will show a loss. yes, i was struck at how little/no specific info about sgai in the annual report. just in the notes, that it a 63% subsid and that its y/e is 31 march ie different to gen. Read Full Thread Follow Reply
02/9/2006 12:49	rambutan2: interims were 30 august last year. certainly been a keen seller around over recent months - low point being a 100k sale at 8.5p on 29 aug. i think the mms deserve a bonus point for that one! elgordo, perhaps the ace in the pack is going to turn out to be the chinese venture? whatever, the current mkt cap certainly offers good upside if gen do strike some gold. and so it should, as there's lots of catching up to do - gen floated in dec 2000 at 210p! Read Full Thread Follow Reply
13/4/2006 21:34	humpja: To double the price of gen would need the 10% of sphere they hold to be rerated to £25m (assuming no dilution in the float). So sphere as a whole needs to be worth at least £250m (10x25) - which seems steep for a company with no sales. Maybe in a few years, but that's still a lot of sensors to shift. Look at CMR - great prospects but because gen has such small holding it isn't likely to set the shareprice on fire. Read Full Thread Follow Reply
10/4/2006 15:48	adejuk: sphere will come to aim in or around sept this year. distribution aggrements should be in place and it is set to take blood analysis to a new level - it may well revolutionise hospital practice adn everyone will want this machine. imho gen could double on just that one float. Read Full Thread Follow Reply
07/2/2006 11:23	games: anyone know if gen still has a stake in British Titanium, as i see they are claiming $400m from Qinetiq. Bit optimistic, but might raise their profile a bit. Read Full Thread Follow Reply
12/12/2005 11:40	kdwilson: I guess that the key impact of this near-term will be to raise GEN's profile. CRM will be seeing lots of institutions who will then also look at GEN. This will lead to interest in other spin offs etc. Still think 20p by March next year possible. Read Full Thread Follow Reply
12/12/2005 07:57	kdwilson: see page 22 of FT - The new non exec Chairman is also subscribing for £1m - that's a major endorsment of CRM. Gen could have something big on its hands...assuming CRM is as good as it looks, the market cap could easily be well north of £60m within 12 months. This on its own means Gen should be worth over 18p...before its other spin offs come to market! Silly price below 15p in my view! Read Full Thread Follow Reply

Advertise Here

Your Recent History

LSE

GEN

Genuit

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20220703 06:40:24